Skip to content
What We Do?
What we do?
Cancer – how it works?
Transplantation – how it works?
Publications and Media
Board and Management
Scientific Advisory Board and Key Opinion Leaders
Amedes Group signs DNA testing licensing agreement with Chronix Biomedical Inc.
Chronix Biomedical: Study Results on Cell-Free DNA Test for Kidney Transplantation Presented at AACC
Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy
Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response to Immunotherapy
Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response in Metastatic Cancers
Chronix Biomedical to Present Clinical Data on Its Cell-Free DNA Approach as an Early Predictor of Response to Chemotherapy at the AACR Annual Meeting
Chronix Biomedical Files Patent Application on Liquid Biopsy
Chronix Biomedical AACR Investor Press Release
Go to Top